Naltrexone
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
Year introduced: 1986 (1976)
PubMed search builder options
Subheadings:
Tree Number(s): D03.132.577.249.706.550, D03.605.497.750.550, D03.633.400.686.750.550, D04.615.723.795.706.550
MeSH Unique ID: D009271
Registry Number: 5S6W795CQM
Entry Terms:
- Trexan
- EN-1639A
- EN1639A
- EN 1639A
- Antaxone
- Celupan
- ReVia
- Nalorex
- Nemexin
- Naltrexone Hydrochloride
Previous Indexing:
Pharmacologic Action: